An unmatched case control study of molar pregnancy was carried out at this hospital between 1978 and 1987 to investigate the influence of maternal age and ethnic group on the incidence of complete and partial hydatidiform mole. The age specific incidence of complete mole was minimal between the ages of 30 and 34 years (relative risk 1), showed a minor peak in teenagers (relative risk 3-1, 95% confidence interval 6-5-1P4), and a major peak in those of 35 years and over. Between 35 and 39 years the relative risk was 2 5 (95% CI 6-2-1 0) and at 40 years or more the relative risk was 9-8 (95% CI 28-9-3-3). No age group showed a significantly increased risk of partial mole.The women of Abu Dhabi had increased risks of both forms of molar pregnancy relative to women in Nottingham, England (relative risk 1): the risk of complete mole was increased threefold (95% CI 42-2-2) and that of partial mole twofold (95% CI 4-0-1-2).The increased risk of complete mole was greatest in Gulf Arabs (mainly Omanis and Yemenis) who had a sixfold increase in crude relative risk (95% CI 10-7-3-5).The increased risks of complete mole associated with maternal ethnic group remained after adjustment for maternal age distribution.
In a combined retrospective and prospective study of the frequency and morphology of hydatidiform mole in A b u Dhabi between 1978 and 1986, the incidence at A1 Corniche Hospital was 2.02 per 1000 deliveries. Morphological classification showed that complete moles formed 80% of the total.The frequency of hydatidiform mole varies geographically but little is known of its incidence in the Arabian Peninsula (Bracken ef al. 1984) or of the relative frequency of the complete and partial forms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.